Federal Register / Vol. 89, No. 212 / Friday, November 1, 2024 / Notices 87385 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public as indicated below in accordance 

with the provisions set forth in section 

552b(c)(6), title 5 U.S.C., as amended for 

the review, discussion, and evaluation 

of individual grant applications 

conducted by the National Institute Of 

Diabetes And Digestive And Kidney 

Diseases, including consideration of 

personnel qualifications and 

performance, and the competence of 

individual investigators, the disclosure 

of which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Board of Scientific 

Counselors, NIDDK. 

Date: April 3–4, 2025. 

Open: April 03, 2025, 10:00 a.m. to 5:00 

p.m. 

Agenda: Introductions and Overview. 

Address: National Institutes of Health, 

Building 10, 10 Center Drive, Bethesda, MD 

20892 (Virtual Meeting). 

Closed: April 04, 2025, 10:00 a.m. to 5:00 

p.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual Investigators. 

Address: National Institutes of Health, 

Building 10, 10 Center Drive, Bethesda, MD 

20892 (Virtual Meeting). 

Contact Person: Michael W. Krause, Ph.D., 

Scientific Director, NIDDK, National Institute 

of Diabetes and Digestive and Kidney 

Diseases, National Institute of Health, 

Building 5, Room B104, Bethesda, MD 

20892–1818, (301) 402–4633, mwkrause@

helix.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: October 28, 2024. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–25418 Filed 10–31–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Center for Scientific 

Review Special Emphasis Panel, PAR 

Panel: Transformative Research Award 

for the Include Project, November 21, 

2024, 09:00 a.m. to November 21, 2024, 

08:00 p.m., National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892, which was 

published in the Federal Register on 

October 25, 2024, FR Doc. No. 2024– 

24882, 89 FR 85222. 

This notice is being amended to 

change the Panel Name of the meeting 

from Center for Scientific Review 

Special Emphasis Panel; PAR Panel: 

Transformative Research Award for the 

Include Project to Center for Scientific 

Review Special Emphasis Panel; RFA– 

OD–22–009: Transformative Research 

Award. The meeting is closed to the 

public. 

Dated: October 28, 2024. 

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–25413 Filed 10–31–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

Catalyze: Enabling Technologies. 

Date: December 4, 2024. 

Time: 2:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge I, 6705 Rockledge Drive, Bethesda, 

MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Kristin Goltry, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review/DERA, National Heart, Lung, and 

Blood Institute, National Institutes of Health, 

6705 Rockledge Drive, Room 209–B, 

Bethesda, MD 20892, (301) 435–0297, email: 

goltrykl@mail.nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

Catalyze: Product Definition. 

Date: December 5, 2024. 

Time: 11:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge I, 6705 Rockledge Drive, Bethesda, 

MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Kristin Goltry, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review/DERA, National Heart, Lung, and 

Blood Institute, National Institutes of Health, 

6705 Rockledge Drive, Room 209–B, 

Bethesda, MD 20892, (301) 435–0297, email: 

goltrykl@mail.nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

T32 Diversity Training Grant Applications 

Review Meeting. 

Date: December 6, 2024. 

Time: 11:00 a.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge I, 6705 Rockledge Drive, Bethesda, 

MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Nawazish Ali Naqvi, 

Scientific Review Officer, Office of Scientific 

Review/DERA, National Heart, Lung and 

Blood Institute, National Institutes of Health, 

6705 Rockledge Drive, Room 208–Y, 

Bethesda, MD 20892, (301) 827–7911, email: 

nawazish.naqvi@nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

NHLBI Institutional Training T32 Member 

Conflict SEP. 

Date: December 9, 2024. 

Time: 10:00 a.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge I, 6705 Rockledge Drive, Bethesda, 

MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Cynthia D. Anderson, 

Ph.D., Scientific Review Officer, Office of 

Scientific Review/DERA, National Heart, 

Lung, and Blood Institute, National Institutes 

Health, 6705 Rockledge Drive, Room 207–E, 

Bethesda, MD 20892, email: 

cynthia.anderson@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: October 29, 2024. 

Bruce A. George, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–25463 Filed 10–31–24; 8:45 am] 

BILLING CODE 4140–01–P 


khammond on DSKJM1Z7X2PROD with NOTICES